Health-care companies rose as traders jumped back into high-risk issues such as obesity drug makers and biotech concerns.
Shares of Novo Nordisk rose by almost 3% and have now almost doubled in the last 12 months, thanks to the ubiquity of its blockbuster weight-control drugs Ozempic and Wegovy.
With a market capitalization of $464 billion, the Danish firm is now more than ten times the size of the next most valuable company on the Copenhagen stock market.
Shares of Corbus Pharmaceuticals rallied after it posted a narrower-than-anticipated quarterly loss.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-12-24 1701ET
